Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22293631 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: genistein;   Other: laboratory biomarker analysis;   Other: placebo;   Procedure: therapeutic conventional surgery;   Other: pharmacological study

Indicates status has not been verified in more than two years